A prospective case-control study in the UK showed that levels of ADAMTS13 in ischemic stroke or TIA patients who received aspirin were reduced in the early stage (≤4 weeks), but increased to normal later (≥3 months). Here, ADAMTS13 is linked to transient ischemic attack.